• 13187 Citations
  • 42 Scopus h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Scott Wright is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Myocardial Infarction Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Unstable Angina Medicine & Life Sciences
Practice Guidelines Medicine & Life Sciences
Advisory Committees Medicine & Life Sciences
Acute Coronary Syndrome Medicine & Life Sciences
Mortality Medicine & Life Sciences
Guidelines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

A New Fix for the Bishop's Hat, Let's Give It Time to Wear Before We Pass Judgment

Murphy, J. G., Luis, S. A. & Wright, R. S., Jan 1 2019, In : Mayo Clinic Proceedings. 94, 1, p. 4-6 3 p.

Research output: Contribution to journalEditorial

Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population

Jentzer, J. C., van Diepen, S., Barsness, G. W., Katz, J. N., Wiley, B. M., Bennett, C., Mankad, S. V., Sinak, L. J., Best, P., Herrmann, J., Jaffe, A. S., Murphy, J. G., Morrow, D. A., Wright, R. S., Bell, M. R. & Anavekar, N. S., Sep 1 2019, In : American Heart Journal. 215, p. 12-19 8 p.

Research output: Contribution to journalArticle

Intensive Care Units
Critical Care
Hospital Mortality
1 Citation (Scopus)

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial

Ray, K. K., Stoekenbroek, R. M., Kallend, D., Nishikido, T., Leiter, L. A., Landmesser, U., Wright, R. S., Wijngaard, P. L. J. & Kastelein, J. J. P., Jan 1 2019, (Accepted/In press) In : JAMA cardiology.

Research output: Contribution to journalArticle

LDL Cholesterol
Randomized Controlled Trials
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies

Wright, R. S., Collins, M. G., Stoekenbroek, R. M., Robson, R., Wijngaard, P. L. J., Landmesser, U., Leiter, L. A., Kastelein, J. J. P., Ray, K. K. & Kallend, D., Jan 1 2019, (Accepted/In press) In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

LDL Cholesterol

Mitigating Risk Patients With Dyslipidemia: A Statin a Day Does Not Always Keep the Doctor Away in Those With Elevated Triglycerides

Wright, R. S. & Murphy, J. G., Sep 1 2019, In : Mayo Clinic proceedings. 94, 9, p. 1659-1661 3 p.

Research output: Contribution to journalEditorial

Hydroxymethylglutaryl-CoA Reductase Inhibitors